Prospective Evaluation of Rate of Hindfoot/Ankle Fusion with Augment Injectable Bone Graft
Category: Hindfoot; Ankle Introduction/Purpose: Augment ® Bone Graft is a mixture of rhPDGF-BB, beta-TCP and bovine collagen which has received FDA approval for use as a substitute for autografts during hindfoot and/or ankle arthrodesis. Although a recent meta analysis demonstrated that the rhPDGF-B...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2024-12-01
|
| Series: | Foot & Ankle Orthopaedics |
| Online Access: | https://doi.org/10.1177/2473011424S00452 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|